New shot delivery method tested in healthy men

NCT ID NCT06951828

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two different devices for giving a single dose of the biologic drug CT-P43: an auto-injector and a pre-filled syringe. It involved 162 healthy men aged 19 to 55. The goal was to see if the two methods deliver the drug similarly into the body and to check for any safety issues.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

CT-P43 (a biologic drug given as a shot under the skin)

What this could lead to

If successful, this could show that the auto-injector works as well as the pre-filled syringe, making it easier for patients to give themselves the medicine.

What could go wrong

This is an early-phase trial in healthy men, not patients. It only checks how the body handles the drug and basic safety, not whether it treats any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY MALE SUBJECTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Korea University Guro Hospital

    Seoul, Guro-gu, 08308, South Korea